Sector
PharmaceuticalsOpen
₹1,624Prev. Close
₹1,618Turnover(Lac.)
₹8,940.4Day's High
₹1,699Day's Low
₹1,608.652 Week's High
₹1,91052 Week's Low
₹987.1Book Value
₹191Face Value
₹1Mkt Cap (₹ Cr.)
22,823.95P/E
295.7EPS
5.68Divi. Yield
0.4413 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
4 Sep 2024
12:00 AM
AGM
Announcement Date: 04 Sep, 2024
The shares were sold at an average price of ₹1,201 each, totalling ₹1,187.41 Crore. Infinity Partners acquired these shares.
Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 13.6 | 13.6 | 14.04 | 13.58 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,510.42 | 2,208.29 | 1,904.51 | 1,561.89 |
Net Worth | 2,524.02 | 2,221.89 | 1,918.55 | 1,575.47 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 1,215.73 | 1,108.83 | 1,020.23 | 760.6 |
yoy growth (%) | 9.64 | 8.68 | 34.13 | 6.69 |
Raw materials | -199.65 | -198.51 | -164.35 | -108.42 |
As % of sales | 16.42 | 17.9 | 16.1 | 14.25 |
Employee costs | -222.18 | -207.01 | -191.73 | -130.84 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 458.53 | 388.89 | 323.59 | 311.88 |
Depreciation | -51.45 | -37.64 | -44.88 | -21.79 |
Tax paid | -41.34 | -38.28 | -32.31 | -18.23 |
Working capital | 85.45 | 2.88 | 111.28 | 52.44 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 9.64 | 8.68 | 34.13 | 6.69 |
Op profit growth | 15.97 | 17.35 | 12.57 | 16.5 |
EBIT growth | 18.44 | 19.73 | 0.97 | 17.3 |
Net profit growth | 18.99 | 20.36 | -0.81 | 18.34 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 2,879.26 | 1,991.3 | 1,661.82 | 1,326.17 | 1,192.64 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,879.26 | 1,991.3 | 1,661.82 | 1,326.17 | 1,192.64 |
Other Operating Income | 14.38 | 17.85 | 23.33 | 20.88 | 19.22 |
Other Income | 18.42 | 23.82 | 11.15 | 26.09 | 8.71 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Amit Indubhushan Bakshi
Whole-time Director
Kaushal Kamlesh Shah
Whole-time Director
Inderjeet Singh Negi
Whole Time Director & COO
Krishnakumar Vaidyanathan
Independent Non Exe. Director
Sujesh Vasudevan
Independent Non Exe. Director
Prashant Gupta
Independent Non Exe. Director
Rajeev Narotam Dalal
Independent Non Exe. Director
Kalpana Unadkat
Company Sec. & Compli. Officer
Milind Talegaonkar
8th Floor Commerce House -IV,
Prahladnagar 100 FT Road,
Gujarat - 380015
Tel: 91-79-30451000
Website: http://www.eris.co.in
Email: [email protected]
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: [email protected]
Summary
Eris Lifesciences Limited was incorporated on January 25, 2007. Subsequently, the name of the company was changed to Eris Lifesciences Private Limited on February 9, 2007. Further, the Company was con...
Read More
Reports by ERIS Lifesciences Ltd
What is the ERIS Lifesciences Ltd share price today?
What is the Market Cap of ERIS Lifesciences Ltd?
What is the PE and PB ratio of ERIS Lifesciences Ltd?
What is the 52 Week High and Low of ERIS Lifesciences Ltd?
What is the CAGR of ERIS Lifesciences Ltd?
What is the shareholding pattern of ERIS Lifesciences Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
